|
|
Volumn 26, Issue 3, 2002, Pages 177-180
|
|
Transimmunization: The science catches up to the clinical success
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
MELANIN;
METHOXSALEN;
PYRIMIDINE;
T LYMPHOCYTE RECEPTOR;
TUMOR ANTIGEN;
ANTIGEN PRESENTATION;
ANTIGEN PRESENTING CELL;
APOPTOSIS;
BASE PAIRING;
CANCER IMMUNOTHERAPY;
CELL FUNCTION;
DENDRITIC CELL;
DISEASE MARKER;
DNA STRAND;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
EDITORIAL;
GRAFT REJECTION;
GRAFT VERSUS HOST REACTION;
HISTORY;
HUMAN;
IMMUNE RESPONSE;
IMMUNIZATION;
LEUKAPHERESIS;
LEUKEMIA CELL;
PHOTOACTIVATION;
PROGNOSIS;
PSORIASIS;
PUVA;
SKIN LYMPHOMA;
SKIN SENSITIZATION;
SUN EXPOSURE;
T LYMPHOCYTE;
TARGET CELL;
TRANSIMMUNIZATION;
TREATMENT OUTCOME;
ULTRAVIOLET RADIATION;
VITILIGO;
IMMUNOTHERAPY;
METHODOLOGY;
NOTE;
HUMANS;
IMMUNOTHERAPY;
PHOTOPHERESIS;
|
|
EID: 0036253323
PISSN: 14730502
EISSN: None
Source Type: Journal
DOI: 10.1016/S1473-0502(02)00010-1 Document Type: Editorial |
|
Times cited : (20)
|
|
References (0)
|
